Zhang, J. (2018). Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors. The Society of Nuclear Medicine (SNM).
Chicago Style (17th ed.) CitationZhang, J. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors. The Society of Nuclear Medicine (SNM), 2018.
MLA (9th ed.) CitationZhang, J. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors. The Society of Nuclear Medicine (SNM), 2018.
Warning: These citations may not always be 100% accurate.